Furthermore, in autoimmune diseases, IDO exerts a protective effect by modulating excessive immune responses via multiple mechanisms: it restricts effector T cell activation, activates aryl hydrocarbon receptor (AhR) to promote Treg cell differentiation, and directly suppresses the release of inflammatory factors such as TNF-α and IL-6 (135, 136). Here, AHR is linked to autoimmune disease.